Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ion channel screening technology.

Michael A Dabrowski1, Kim Dekermendjian, Per-Eric Lund

  • 1Department of Molecular Pharmacology, Local Discovery RA CNS & Pain Control, Astrazeneca R&D Södertälje, SE-151 85 Södertälje, Sweden.

CNS & Neurological Disorders Drug Targets
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reverse transcriptase mediated signal amplification in ligand binding assays.

SLAS technology·2026
Same author

Dynamic recruitment of Munc13 primes docked secretory granules for exocytosis.

Cell reports·2025
Same author

RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.

Diabetologia·2024
Same author

Macromolecular characterization of high β-glucan oat lines.

Heliyon·2024
Same author

Pupil light reflex dynamics in Parkinson's disease.

Frontiers in integrative neuroscience·2023
Same author

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status.

Movement disorders clinical practice·2023
Same journal

Role of Cholesterol Metabolism in the Link Between Diabetes and Alzheimer's Disease.

CNS & neurological disorders drug targets·2026
Same journal

Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies.

CNS & neurological disorders drug targets·2026
Same journal

Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer's Disease Prevention and Management.

CNS & neurological disorders drug targets·2026
Same journal

The Therapeutic Effects of Dietary Supplements on OCD: A Narrative Review.

CNS & neurological disorders drug targets·2026
Same journal

Amyotrophic Lateral Sclerosis: Therapeutic Innovations and Evolving Regulatory Approaches.

CNS & neurological disorders drug targets·2026
Same journal

Pathogenic Proteins Driving ALS Pathogenesis: Molecular Mechanisms and Translational Therapeutic Perspectives.

CNS & neurological disorders drug targets·2026
See all related articles

Novel screening technologies are overcoming historical bottlenecks in ion channel drug discovery. This enables the development of new therapeutic agents for diseases like cancer, diabetes, and pain.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Ion channels represent the third-largest target class in drug discovery.
  • They are implicated in diverse diseases including cancer, diabetes, pain, and neurological disorders.
  • Despite their importance, ion channels remain under-exploited due to historical limitations in screening technologies.

Purpose of the Study:

  • To review current technologies for ion channel screening.
  • To discuss the opportunities presented by these novel technologies.
  • To highlight remaining challenges in the field.

Main Methods:

  • Review of existing literature on ion channel screening technologies.
  • Analysis of technological advancements and their integration into drug discovery pipelines.

Related Experiment Videos

  • Discussion of the impact of these technologies on lead generation.

    • Main Results:

    • Significant advancements in screening technologies are addressing historical throughput and data quality limitations.
    • Novel technologies facilitate the integration of ion channel screening into early drug discovery stages.
    • These advancements offer new opportunities for developing therapeutic agents targeting ion channels.

    Conclusions:

    • The development of advanced screening technologies is crucial for unlocking the therapeutic potential of ion channels.
    • Continued innovation is needed to overcome remaining technical challenges.
    • Exploiting ion channel targets holds promise for novel treatments across various diseases.